157 related articles for article (PubMed ID: 7753548)
21. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
22. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.
Purdie CA; Harrison DJ; Peter A; Dobbie L; White S; Howie SE; Salter DM; Bird CC; Wyllie AH; Hooper ML
Oncogene; 1994 Feb; 9(2):603-9. PubMed ID: 8290271
[TBL] [Abstract][Full Text] [Related]
23. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS
Oncogene; 1996 Dec; 13(11):2407-13. PubMed ID: 8957082
[TBL] [Abstract][Full Text] [Related]
24. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L
Cancer Res; 2000 Jun; 60(11):2831-5. PubMed ID: 10850423
[TBL] [Abstract][Full Text] [Related]
25. Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after gamma-irradiation.
Ohi H; Mishima Y; Kamimura K; Maruyama M; Sasai K; Kominami R
Oncogene; 2007 Aug; 26(36):5280-9. PubMed ID: 17325664
[TBL] [Abstract][Full Text] [Related]
26. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
[TBL] [Abstract][Full Text] [Related]
27. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
28. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
29. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
30. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R
Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
[TBL] [Abstract][Full Text] [Related]
33. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
34. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
36. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
Thompson TC; Park SH; Timme TL; Ren C; Eastham JA; Donehower LA; Bradley A; Kadmon D; Yang G
Oncogene; 1995 Mar; 10(5):869-79. PubMed ID: 7534899
[TBL] [Abstract][Full Text] [Related]
37. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
38. Infrequent p53 mutation in mouse tumors with deregulated myc.
Gutierrez MI; Bhatia K; Siwarski D; Wolff L; Magrath IT; Mushinski JF; Huppi K
Cancer Res; 1992 Feb; 52(4):1032-5. PubMed ID: 1737333
[TBL] [Abstract][Full Text] [Related]
39. Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice.
Spanopoulou E; Early A; Elliott J; Crispe N; Ladyman H; Ritter M; Watt S; Grosveld F; Kioussis D
Nature; 1989 Nov; 342(6246):185-9. PubMed ID: 2572968
[TBL] [Abstract][Full Text] [Related]
40. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development.
Aspinall R
J Immunol; 1997 Apr; 158(7):3037-45. PubMed ID: 9120255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
